AU542824B2 - Sustained release pharmaceuticals - Google Patents

Sustained release pharmaceuticals

Info

Publication number
AU542824B2
AU542824B2 AU65976/81A AU6597681A AU542824B2 AU 542824 B2 AU542824 B2 AU 542824B2 AU 65976/81 A AU65976/81 A AU 65976/81A AU 6597681 A AU6597681 A AU 6597681A AU 542824 B2 AU542824 B2 AU 542824B2
Authority
AU
Australia
Prior art keywords
sustained release
release pharmaceuticals
pharmaceuticals
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU65976/81A
Other languages
English (en)
Other versions
AU6597681A (en
Inventor
James Michael Dunn
John Francis Lampard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of AU6597681A publication Critical patent/AU6597681A/en
Application granted granted Critical
Publication of AU542824B2 publication Critical patent/AU542824B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU65976/81A 1980-01-11 1981-01-05 Sustained release pharmaceuticals Ceased AU542824B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US111430 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments
US194453 1980-10-17

Publications (2)

Publication Number Publication Date
AU6597681A AU6597681A (en) 1981-07-16
AU542824B2 true AU542824B2 (en) 1985-03-14

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65976/81A Ceased AU542824B2 (en) 1980-01-11 1981-01-05 Sustained release pharmaceuticals

Country Status (22)

Country Link
JP (1) JPS56103110A (instruction)
AT (1) AT374681B (instruction)
AU (1) AU542824B2 (instruction)
BE (1) BE886998A (instruction)
CA (1) CA1140466A (instruction)
CH (1) CH646604A5 (instruction)
DE (1) DE3100191A1 (instruction)
DK (1) DK6181A (instruction)
ES (2) ES498369A0 (instruction)
FI (1) FI76927C (instruction)
FR (1) FR2473308B1 (instruction)
GB (1) GB2067072B (instruction)
GR (1) GR73843B (instruction)
IE (1) IE50806B1 (instruction)
IN (1) IN151913B (instruction)
IT (1) IT1221041B (instruction)
LU (1) LU83052A1 (instruction)
NL (1) NL8100037A (instruction)
NO (1) NO156153C (instruction)
NZ (1) NZ195933A (instruction)
SE (1) SE447450B (instruction)
ZA (1) ZA81136B (instruction)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3486029T2 (de) * 1983-10-14 1993-05-13 Sumitomo Pharma Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
CA1277601C (en) * 1985-12-27 1990-12-11 Shigeji Sato Method for producing sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
WO1997002019A1 (en) 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
BE604564A (instruction) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
FI76927B (fi) 1988-09-30
GB2067072A (en) 1981-07-22
FR2473308A1 (fr) 1981-07-17
JPS56103110A (en) 1981-08-18
GR73843B (instruction) 1984-05-07
NO156153C (no) 1987-08-05
IE50806B1 (en) 1986-07-23
NO810062L (no) 1981-07-13
FI810056L (fi) 1981-07-12
ZA81136B (en) 1982-01-27
DK6181A (da) 1981-07-12
CH646604A5 (fr) 1984-12-14
IT1221041B (it) 1990-06-21
IN151913B (instruction) 1983-09-03
ES8205353A1 (es) 1982-06-01
DE3100191C2 (instruction) 1988-09-01
SE447450B (sv) 1986-11-17
ES509179A0 (es) 1982-12-16
NO156153B (no) 1987-04-27
NL8100037A (nl) 1981-08-03
DE3100191A1 (de) 1981-12-10
IE810036L (en) 1981-07-11
ATA5481A (de) 1983-10-15
CA1140466A (en) 1983-02-01
NZ195933A (en) 1982-11-23
GB2067072B (en) 1983-08-10
SE8100104L (sv) 1981-07-12
AT374681B (de) 1984-05-25
ES498369A0 (es) 1982-06-01
LU83052A1 (fr) 1982-09-10
ES8301629A1 (es) 1982-12-16
FR2473308B1 (fr) 1985-07-19
FI76927C (fi) 1989-01-10
BE886998A (fr) 1981-07-08
IT8147537A0 (it) 1981-01-09
AU6597681A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
AU537992B2 (en) Polusilanes
AU547768B2 (en) Display system
AU523878B2 (en) Fire-extinguisher system
AU532489B2 (en) Sprinkler system
AU541995B2 (en) m
AU557693B2 (en) Pharmaceutical sustained release compounds
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU539188B2 (en) Skin-packaging
AU536754B2 (en) Imidodisulfamides
AU3206284A (en) 2-guanidno-4-heteroarylthiazoles
AU542824B2 (en) Sustained release pharmaceuticals
AU547532B2 (en) Microcapsule
AU527275B2 (en) Auto-diaphragm hemodialyser
AU537824B2 (en) Oxygensensor
AU6892581A (en) Alarm system
AU541056B2 (en) Pharmaceuticals formulations
AU6860981A (en) Checkout system
AU549299B2 (en) Sustained release theophylline tablet
AU539565B2 (en) If amilifier
AU534814B2 (en) Showstand
AU6481780A (en) Alarm system
AU517843B2 (en) Guanylamidines
AU538427B2 (en) Dichlorobenzoyl-3-phenylpyrazolines
AU538275B2 (en) 4-carbamyloxy-oxazaphosphorins
AU525004B2 (en) Phthalimidoguanidines